Bracco is a multinational life science company and leader in diagnostic imaging, developing contrast agents, medical devices and advanced imaging solutions.
Bracco is a multinational life science company and a world leader in diagnostic imaging. Founded in 1927, the group develops, manufactures and markets contrast agents, medical devices and advanced diagnostic imaging solutions, serving professionals and patients across more than 100 countries. It employs around 4,000 people and records annual revenue of approximately €2.0 billion.
The company's technical work spans contrast media, medical devices supporting imaging procedures, imaging diagnostics and broader research in precision and preventive medicine. Its product portfolio comprises contrast agents designed to improve the diagnostic imaging journey, medical devices for imaging procedures, and advanced imaging solutions built around increasingly advanced and sustainable techniques.
Research and development is central to the business: 8% of turnover is reinvested in R&D, supported by 11 innovation centres worldwide and a portfolio of over 2,500 active patents. Bracco states a people-centric purpose - "our journey starts and ends with people" - and directs its work towards prevention, precision medicine and improving people's lives.
